Free Trial
TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

Resverlogix logo
C$0.08 0.00 (0.00%)
As of 10/9/2026 03:35 PM Eastern

About Resverlogix Stock (TSE:RVX)

Advanced

Key Stats

Today's Range
C$0.09
▼
C$0.09
50-Day Range
C$0.09
▼
C$0.11
52-Week Range
C$0.08
▼
C$0.15
Volume
2,000 shs
Average Volume
33,108 shs
Market Capitalization
C$29.26 million
P/E Ratio
N/A
Dividend Yield
7.02%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients' lives by restoring biological functions - altered by serious illnesses such as cardiovascular disease - back to a healthier state. The Company's clinical program is focused on evaluating the lead epigenetic candidate apabetalone for the treatment of cardiovascular disease, associated comorbidities, and post COVID-19 conditions.

Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RVX Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Headlines

RVX Stock Analysis - Frequently Asked Questions

Resverlogix's stock was trading at C$0.10 at the beginning of 2026. Since then, RVX shares have decreased by 15.0% and is now trading at C$0.09.

Resverlogix Corp. (TSE:RVX) issued its earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.03) earnings per share for the quarter.

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resverlogix investors own include FuelCell Energy (FCEL), Sorrento Therapeutics (SRNE), Aurora Cannabis (ACB), Algonquin Power & Utilities (AQN), Antibe Therapeutics (ATE), BCE (BCE) and Burcon NutraScience (BU).

Company Calendar

Last Earnings
11/12/2024
Today
10/13/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:RVX
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.81 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
10.92%
Return on Assets
-34.90%

Debt

Debt-to-Equity Ratio
-82.47
Current Ratio
0.04
Quick Ratio
0.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
132.50
Book Value
C($0.29) per share
Price / Book
-0.30

Miscellaneous

Outstanding Shares
344,287,000
Free Float
N/A
Market Cap
C$29.26 million
Optionable
Not Optionable
Beta
-0.11
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (TSE:RVX) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners